Market players are adopting organic and inorganic growth strategies to expand their footprint in the lung cancer screening market by accounting largest share. In June 2022, Royal Philips announced to have teamed up with Biodesix, Inc. to incorporate the results of Biodesix’s Nodify Lung blood-based lung nodule risk assessment testing into Philips Lung Cancer Orchestrator […]